Applied Information Named Official Video Sponsor for ITS World Congress 2025 in Atlanta, GA
Applied Information has produced a special video series, Insider's Guide to Atlanta
ITS World Congress 2025, organized in partnership by RX and ITS America (ITSA), and themed 'Deploying Today, Empowering Tomorrow,' is a premier global event showcasing the latest in intelligent transportation technologies. Applied Information will provide video coverage throughout the week, including interviews with industry leaders, highlights of real-world technology demonstrations, and insights into how connected and autonomous vehicle solutions are improving safety, mobility, and efficiency.
In addition to video coverage, Applied Information will host an official ITSWC Tech Tour at the Infrastructure Automotive Technology Laboratory (iATL®), located in Alpharetta. The iATL is the world's first private-sector lab built to test and deploy real-world intelligent transportation system (ITS) solutions. The tour offers a hands-on look at advanced transportation technologies in action, both inside the lab and on the streets of Alpharetta. Attendees will see live demonstrations of signal priority for emergency vehicles, school zone safety systems, and technologies designed to protect vulnerable road users. Registration for the iATL tour is now open and attendees are encouraged to reserve their spot early.
To support attendee preparation, Applied Information has produced a special video series, Insider's Guide to Atlanta, offering practical tips for arriving at Hartsfield-Jackson International Airport, using MARTA transit, and navigating downtown Atlanta. All pre-event and in-conference video updates, including local guidance and technology coverage, will be posted to Applied Information's ITSWC 2025 YouTube playlist. Viewers are encouraged to subscribe for ongoing updates throughout the event.
About Applied Information, Inc.
In 2011, Applied Information® transformed the traffic industry by using Internet of Things technology to make school zones safer for students. Today, Applied Information makes it easy to see and manage all types of traffic control devices from anywhere, on your phone or in a browser. Our Glance® technology provides hardware, software, communications, cloud computing and cutting-edge Connected and Autonomous Vehicle Applications in one easy-to-use solution.
Applied Information's customers, partners and employees create a safer and more reliable travel experience for millions of drivers, pedestrians, cyclists, bus riders and first responders across North America. For more information, visit www.appinfoinc.com.
About ITS America Events
ITS America Events, managed by RX, encompassing ITS America Conference & Expo and ITS World Congress when in North America, brings together decision-makers and their supporting teams from public and private sector transportation agencies to learn about the implementation of new technologies, work together to advance mobility solutions that will enable a safer, greener, and smarter transportation system across the globe.
About ITS America
The Intelligent Transportation Society of America advances the research and deployment of intelligent transportation technologies to save lives, improve mobility, promote sustainability, and increase efficiency and productivity. Our vision is a better future transformed by transportation technology and innovation: Safe, Smart, Connected. For more information, please visit www.itsa.org.
About RX
RX is in the business of building businesses for individuals, communities, and organizations. We elevate the power of face-to-face events by combining data and digital products to help customers learn about markets, source products and complete transactions at over 400 events in 22 countries across 43 industry sectors. RX is passionate about making a positive impact on society and is fully committed to creating an inclusive work environment for all our people. RX is part of RELX, a global provider of information-based analytics and decision tools for professional and business customers.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
17 hours ago
- Business Wire
Rhythm Express Named by Inc. Magazine as One of the Fastest Growing Private Firms in America
MINNEAPOLIS--(BUSINESS WIRE)-- VivaQuant, Inc. d.b.a. Rhythm Express, a leader in remote cardiac monitoring and digital health solutions, has been recognized as one of the fastest-growing private companies in the United States by Inc. Magazine for the third consecutive year, ranking #331. VivaQuant's continued recognition reflects the company's momentum in reshaping the future of cardiac care through intelligent remote monitoring technologies. 'We are proud of the accomplishments of our team. This is a tremendous honor to make this prestigious list for the third consecutive year. It's a powerful validation of the work we're doing to make cardiac care more accessible, efficient and effective,' said Brian Brockway, CEO of VivaQuant. 'This milestone belongs to our entire team and the providers and patients who trust our solutions every day. We're proud to be driving meaningful change in patient outcomes through our Rhythm Express business and cutting-edge monitoring technologies.' 'This milestone belongs to our entire team and the providers and patients who trust our solutions every day.' — Brian Brockway, CEO Share Innovating the Future of Remote Cardiac Monitoring VivaQuant's flagship offering, Rhythm Express, delivers advanced, near-real time cardiac diagnostics via the small, one-piece, cellular enabled RX-1 mini ™ wearable device and Rhythm Access Portal™. The platform is designed to meet the growing demand for accurate, scalable and user-friendly remote cardiac monitoring services. With a continued focus on innovation and clinical excellence, VivaQuant is well-positioned to lead the next generation of digital cardiovascular care. About VivaQuant, Inc. VivaQuant, Inc. is a digital health company specializing in remote cardiac monitoring and diagnostic services. Through its Rhythm Express platform, VivaQuant combines cutting-edge wearable technology, enhanced proprietary noise removal & analytics, and clinical insight to support better outcomes for patients and providers nationwide.
Yahoo
7 days ago
- Yahoo
Gentuity LLC Announces Agreement to Collaborate with GE HealthCare to Expand Access to Advanced Intravascular Imaging Platform
SUDBURY, Mass., Aug. 7, 2025 /PRNewswire/ -- Gentuity LLC, a Massachusetts-based medical technology company specializing in next-generation intravascular imaging devices, today announced an agreement with GE HealthCare to collaborate on commercial activities. The collaboration is intended to enhance the availability, adoption, and functionality of highly complementary imaging solutions for interventional cardiology. As part of the agreement, Gentuity and GE HealthCare aim to jointly pursue co-marketing initiatives and technical integration of their respective technologies. GE HealthCare also plans to explore opportunities to expand access to Gentuity's innovative products through its own distribution network in the United States. These products include: High-Frequency OCT Imaging System: A mobile console powered by machine learning technology, offering rapid setup and detailed imaging capabilities. Vis-Rx® Prime Micro-Imaging Catheter: The world's smallest imaging catheter at 1.8F, designed for comprehensive vessel imaging before and after percutaneous coronary intervention (PCI) procedures. "We are thrilled at the opportunity to expand our relationship with GE HealthCare and look forward to bringing our advanced imaging solutions to a broader range of healthcare providers," said Desmond Adler, President of Gentuity. "Our industry best serves our physicians and patients when we thoughtfully combine complementary technologies in a way that amplifies their individual impact, and we see this collaboration as an important enabling step in that direction." Founded in 2015, Gentuity is an established leader in the development of advanced intravascular imaging technologies possessing excellent usability and performance. The company's proprietary platform integrates artificial intelligence tools and user-centric design to reduce operator burden with the goal of improving procedural success, extending the known clinical benefits and cost efficiencies of intravascular imaging to a broader range of patients. "At GE HealthCare, we strive to tell the story of the heart through technologies that help diagnose, treat and monitor cardiovascular conditions," said Jyoti Gera, CEO, CardioVascular and Interventional Solutions at GE HealthCare. "This joint initiative with Gentuity supports this mission and reflects our shared commitment to delivering high-quality medical devices that that enhance patient outcomes and quality of life." For more information about Gentuity's products and this agreement, please visit or contact info@ Forward-Looking Statements This release contains forward looking statements. These forward-looking statements might be identified by words, and variations of words, such as "will," "expect," "may," "would," "could," "plan," "believe," "anticipate," "intend," "aim," "estimate," "potential," "position," and similar expressions. These forward-looking statements may include, but are not limited to, statements about the collaboration, the anticipated outcomes of the collaboration, and any new products or solutions resulting from the collaboration or otherwise. These forward-looking statements involve risks and uncertainties, many of which are beyond the control of the Company. Factors that could cause the Company's actual results to differ materially from those described in its forward-looking statements include, but are not limited to, the Company's inability to achieve the anticipated benefits of this collaboration, business or commercial disruptions, and unexpected risks and liabilities impacting the Company. There may be other factors not presently known to the Company or which it currently considers to be immaterial that could cause the Company's actual results to differ materially from those projected in any forward-looking statements the Company makes. The Company does not undertake any obligation to update or revise its forward-looking statements except as required by applicable law or regulation. Media Contact: Gentuity LLCEmail: info@ +1 888-967-7628 About Gentuity LLC: Gentuity LLC is a medical technology company dedicated to developing next-generation intravascular imaging devices. Based in Sudbury, Massachusetts, Gentuity focuses on crossing new frontiers in cardiovascular care so patients can focus on living. View original content to download multimedia: SOURCE Gentuity, LLC
Yahoo
31-07-2025
- Yahoo
SiebenCarey Attorney Susan M. Holden Inducted Into the International Academy of Trial Lawyers
With Only 500 Members Nationwide, Holden in Elite Company Minneapolis, Minnesota--(Newsfile Corp. - July 31, 2025) - Susan M. Holden of Minneapolis-based SiebenCarey Personal Injury Law was inducted as a Fellow into the International Academy of Trial Lawyers (IATL) during the organization's recent 2025 Mid-Year Meeting. "Selection as a Fellow at the Academy represents a pinnacle career accomplishment in the legal profession," said Jim Carey, SiebenCarey's managing partner. "It's the real deal, and no surprise to us. Susan has served her clients and the profession at the highest levels, earning her place among the giants of the trial Bar." The International Academy of Trial Lawyers is an invitation-only fellowship of lawyers with a singular mission-to protect and promote the Rule of Law. Founded in 1954, the Academy comprises the world's top trial lawyers, as measured by skill, experience, ethics, and civility. It represents both sides of the trial bar: prosecutors and defense lawyers in criminal cases; plaintiff and defense counsel in civil litigation. "Standing shoulder to shoulder with so many remarkable lawyers was truly humbling and inspiring," Holden said of the induction ceremony held July 25, in Vancouver, British Columbia. "I look forward to furthering the Academy's mission to learn, mentor, and drive justice forward." Holden's peers have also selected her for several of the profession's other most prestigious membership organizations, including the American College of Trial Lawyers, the International Society of Barristers, and the American Board of Trial Advocates. Holden also earned certification as a Civil Trial Specialist by the Minnesota State Bar Association in 1995, a distinction held by fewer than 1% of Minnesota lawyers. Holden's primary practice area is personal injury and wrongful death cases. She is a partner at SiebenCarey and has been representing injured individuals and their families at the firm since graduating from Mitchell Hamline School of Law in 1988. She currently resides in Blaine, Minn. IATL president Joe H. Tucker, Jr. (center right) presents the award recognizing SiebenCarey attorney Susan M. Holden (center left) as an Academy Fellow. Also pictured are Holden's husband Brian Gaviglio (far left) and Theresa Bevilacqua, the Minnesota attorney with Dorsey & Whitney who introduced Holden for induction. To view an enhanced version of this graphic, please visit: About Fellowship in the International Academy of Trial Lawyers The Academy stands as the world's foremost trial lawyer organization, dedicated to excellence, advocacy, and legal reform. The membership includes 500 active trial lawyers in the United States and over 150 Fellows from 30 countries, representing both plaintiffs and defendants in civil cases, as well as prosecutors and criminal defense lawyers. For more information, visit: About SiebenCarey Founded in 1952, SiebenCarey is one of Minnesota's largest and most widely respected personal injury law firms, successfully representing over 70,000 injury victims. For over 70 years, the firm has employed experienced lawyers and professional staff to handle personal injury, workers' compensation, wrongful death, and medical malpractice claims. The offices are located throughout Minnesota in Minneapolis, Lakeville, and Duluth. For more information, visit: # # # Media Inquiries Steve Miller on behalf of SiebenCarey612-860-8623slm@ Kevin GriffinInternational Academy of Trial LawyersExecutive Officepress@ To view the source version of this press release, please visit
